361 related articles for article (PubMed ID: 2239873)
1. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
Fiorucci S; Santucci L; Morelli A
Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
[TBL] [Abstract][Full Text] [Related]
2. Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus.
Fiorucci S; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1989 Oct; 84(10):1263-7. PubMed ID: 2801676
[TBL] [Abstract][Full Text] [Related]
3. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
4. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
5. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
6. [Reduced suppression of gastric acid by ranitidine in severe reflux esophagitis. A pilot study].
Koop H; Klein M; Bauer A; Arnold R
Z Gastroenterol; 1988 Jul; 26(7):345-50. PubMed ID: 3223004
[TBL] [Abstract][Full Text] [Related]
7. Empiric therapy for gastroesophageal reflux disease.
Schindlbeck NE; Klauser AG; Voderholzer WA; Müller-Lissner SA
Arch Intern Med; 1995 Sep; 155(16):1808-12. PubMed ID: 7654116
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
9. Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease.
Tefera S; Hatlebakk JG; Berstad A
Am J Gastroenterol; 2001 Apr; 96(4):969-74. PubMed ID: 11316213
[TBL] [Abstract][Full Text] [Related]
10. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
Collen MJ; Strong RM
Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
[TBL] [Abstract][Full Text] [Related]
11. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
[TBL] [Abstract][Full Text] [Related]
12. Chest pain associated with nutcracker esophagus: a preliminary study of the role of gastroesophageal reflux.
Achem SR; Kolts BE; Wears R; Burton L; Richter JE
Am J Gastroenterol; 1993 Feb; 88(2):187-92. PubMed ID: 8424418
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
[TBL] [Abstract][Full Text] [Related]
15. [Reflux esophagitis: therapy with H2-blockers, and motility disorders].
Pace F; Sangaletti O; Zhu H; Bianchi Porro G
Minerva Chir; 1991 Apr; 46(7 Suppl):163-7. PubMed ID: 2067675
[TBL] [Abstract][Full Text] [Related]
16. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
[TBL] [Abstract][Full Text] [Related]
17. A comparison of five maintenance therapies for reflux esophagitis.
Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
[TBL] [Abstract][Full Text] [Related]
18. The role of omeprazole in healing and prevention of reflux disease.
Klinkenberg-Knol EC
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
[TBL] [Abstract][Full Text] [Related]
19. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.
Bianchi Porro G; Pace F; Peracchia A; Bonavina L; Vigneri S; Scialabba A; Franceschi M
J Clin Gastroenterol; 1992 Oct; 15(3):192-8. PubMed ID: 1479161
[TBL] [Abstract][Full Text] [Related]
20. Comparison of omeprazole and famotidine on esophageal pH in patients with moderate to severe esophagitis: a cross-over study.
Ducrotté P; Guillemot F; Elouaer-Blanc L; Hirschauer C; Thorel JM; Petit A; Hochain P; Michel P; Cortot A; Colin R
Am J Gastroenterol; 1994 May; 89(5):717-21. PubMed ID: 8172144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
